NAD and Addiction

BR+NAD REDUCES CRAVINGS

Intravenous Administration of Nicotinamide Adenine Dinucleotide Significantly Reduces Self Report Craving Ratings Associated with Opiate and Alcohol Withdrawal*

IV NAD EVALUATING AND REFINING ASSESSMENT OF WITHDRAWAL SYMPTOMS ASSOCIATED WITH OPIOID AND ALCOHOL USE DISORDERS

LL23 Evaluating and refining assessment of withdrawal symptoms associated with opioid and alcohol use
disorders using Intravenous administration of nicotinamide adenine dinucleotide detox protocols

IV NAD SIGNIFICANTLY IMPROVES WITHDRAWAL SYMPTOMS ASSOCIATED WITH CHRONIC OPIOID EXPOSURE

Intravenous Administration of Nicotinamide Adenine Dinucleotide Significantly Improves Withdrawal Symptoms Associated with Chronic Opioid Exposure

THERAPEUTIC EFFECT OF BR+NAD ON OPIOID AND ALCOHOL WITHDRAWAL

Therapeutic Effect of 𝑩𝑹+𝑵𝑨𝑫® on Opioid and Alcohol Withdrawal: Implications for Clinical Populations